Recruiting NA Autonomic Nerve Block

New treatment option for Autonomic Nerve Block

Official title Sternotomy PIFB Block in Open Heart Surgery

ClinicalTrials.gov ID: NCT06233318

What this study is testing

What it's testing
The purpose of this study is to evaluate if the use of a bilateral nerve block with a local anesthetic (ropivacaine), as part of a standard of care pain control regimen (called multimodal analgesia [MMA]), has a favorable effect on our institutional MMA pain regimen. Subjects will go through the following study procedures: review of medical history and medications subjects have taken within a month prior to surgery.
  • You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance. You may not know which one you got.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 and older

You may be able to join if

  • Adult male or female patients aged \> 18
  • Undergoing primary cardiac surgery requiring sternotomy
  • Able to provide a signed written informed consent
  • Able to speak, read, and write in English
  • American Society of Anesthesiologists (ASA) physical status I-IV

You likely can't join if

  • Any documented cognitive or psychological disorders that, in the opinion of the principal investigator, can interfere with the patients' pain...
  • Diabetes Mellitus with documented neuropathic pain
  • Vulnerable populations: pregnant females, prisoners, breast feeding
  • Contraindication to nerve block: local infections, bleeding disorders, chest wall deformity, allergy to local anesthetic or dexamethasone
  • Previous cardiac surgery
  • Previous history of chronic pain diseases requiring consistent analgesic therapy for at least 1 month prior to surgery
See the full eligibility criteria
Who can join
  • Adult male or female patients aged \> 18
  • Undergoing primary cardiac surgery requiring sternotomy
  • Able to provide a signed written informed consent
  • Able to speak, read, and write in English
  • American Society of Anesthesiologists (ASA) physical status I-IV
What rules you out
  • Any documented cognitive or psychological disorders that, in the opinion of the principal investigator, can interfere with the patients' pain perception
  • Diabetes Mellitus with documented neuropathic pain
  • Vulnerable populations: pregnant females, prisoners, breast feeding
  • Contraindication to nerve block: local infections, bleeding disorders, chest wall deformity, allergy to local anesthetic or dexamethasone
  • Previous cardiac surgery
  • Previous history of chronic pain diseases requiring consistent analgesic therapy for at least 1 month prior to surgery
  • Presence of any medical condition that, in the opinion of the principal investigator, should exclude the patient from the study
  • BMI ≥ 40 kg/m2

The study team makes the final eligibility decision.

Where it's taking place

  • Columbus, Ohio, United States

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Columbus, Ohio, United States. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.